Pay particular attention to IGF-1 levels (which should rise with Tesamorelin but stay within a healthy reference range), fasting glucose and insulin (to monitor for any GH-related insulin resistance), liver enzymes (both compounds have liver-protective effects, but monitoring confirms this), and lipid panels (you should see improvements in triglycerides and LDL)
The pivotal programs include STEP for semaglutide in weight management (published in The New England Journal of Medicine , 2021), SURMOUNT for tirzepatide in weight management (NEJM 2022), and SURMOUNT-OSA for tirzepatide in obstructive sleep apnea (NEJM 2024)
These rules help healthcare professionals give safe and effective treatment
Mehta reviews the AI's plan, refines it in your visit, and the apps adapt as your weight, labs, and habits change month over month
Finally, a discussion emerged regarding a specific population that may significantly benefit from combined therapy: individuals with obesity and T2D and high or very high cardiovascular risk or obesity